Home » Topics » Regulatory » Patents

Patents
RSS

New selective 5-HT1B receptor antagonists disclosed by Astra (AstraZeneca)

May 13, 1999

New class of CETP inhibitors useful for lipid disorders and coronary artery disease

May 12, 1999

Asahi Glass describes dual NK1/NK2 antagonists

May 12, 1999

SmithKline Beecham identifies new anticonvulsant ureas

May 12, 1999

Antagonists of MIP-1alpha/RANTES receptor disclosed by Takeda

May 12, 1999

Selective human 5-HT1B receptor ligands in development at AstraZeneca

May 12, 1999

New carbapenems with excellent in vitro and in vivo profile designed by Korean scientists

May 12, 1999

Almirall Prodesfarma patents new series of selective COX-2 inhibitors

May 11, 1999

Substituted indan derivatives with selective affinity for 5-HT1B receptors

May 11, 1999

Antiallergic/antiinflammatory agents in the Nikken Chemicals pipeline

May 11, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...